Your search returned 4 results.

Results
	1.	Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer. [electronic resource] by Callagy, Grace M Webber, Mark J Pharoah, Paul D P Caldas, Carlos Producer: 20080715 In: BMC cancer vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index. [electronic resource] by Callagy, Grace M Pharoah, Paul D Pinder, Sarah E Hsu, Forrest D Nielsen, Torsten O Ragaz, Joseph Ellis, Ian O Huntsman, David Caldas, Carlos Producer: 20061030 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy. [electronic resource] by Walsh, Elaine M Shalaby, Aliaa O'Loughlin, Mark Keane, Nessa Webber, Mark J Kerin, Michael J Keane, Maccon M Glynn, Sharon A Callagy, Grace M Producer: 20190708 In: Breast cancer research and treatment vol. 174 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene. [electronic resource] by Huang, Huai-En Chin, Suet-Feung Ginestier, Christophe Bardou, Valérie-Jeanne Adélaïde, José Iyer, N Gopalakrishna Garcia, Maria J Pole, Jessica C Callagy, Grace M Hewitt, Stephen M Gullick, William J Jacquemier, Jocelyne Caldas, Carlos Chaffanet, Max Birnbaum, Daniel Edwards, Paul A W Producer: 20041116 In: Cancer research vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)